Overview
Status
Active
Registry date
2011-04-19
Share capital
5,000.00 PLN
Registered address
ul. Zygmunta Słomińskiego 15/509, 00-195 Warszawa, Poland
Financials
Filing timeliness
No financial statement for 2019 – the filing deadline has passed. 1 of 1 financial statements was filed late (for 2018, 23 days late).
- 2019not filed
- 201807/08/2019
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Industry
Authorized Representatives
Adam Wonciszage 41 – Vice President of the Management Board
Anna Aranowska-Bablokage 46 – President of the Management Board
Oron David Zachar – Vice President of the Management Board
Manner of representation
The joint action of two members of the management board is required to submit signatures and declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Adam Mikołaj Wonciszage 41 | 35 | $945.43 | 70% |
Oron David Zachar | 15 | $405.19 | 30% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| FamicordtxS.A. | $1,365,068.41 | famicordtx.com | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Explorna Therapeuticssp. z o.o. | $304,662.00 | explorna.com | ||
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| LASTsp. z o.o. | – | last-skincare.com | ||
| Nawah Scientific Polandsp. z o.o. | – | nawah-scientific.com |
Change history
| Date | Event | |
|---|---|---|
| 2017-01-24 | Address change (Rydygiera 8/3a, 01-793, Warszawa → Ul. Zygmunta Słomińskiego 15/509, 00-195, Warszawa) | |
| 2017-01-24 | PKD change (Removed: 10 codes; Added: 2 codes) | |
| 2011-10-21 | Address change (Nowogrodzka 50/515, 00-695, Warszawa → Rydygiera 8/3a, 01-793, Warszawa) | |
| 2011-10-21 | Name change (Magger Investment → Prodolux) | |
| 2011-10-21 | PKD change (Removed: 13 codes; Added: 17 codes) |
FAQ
The main business activity of Prodolux focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on April 19, 2011.
The headquarters is located at: ul. Zygmunta Słomińskiego 15, 00-195 Warszawa.
The management board includes Anna Aranowska Bablok (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2018 to December 31, 2018.
Last updated: 2026-04-20